04.02.2015 Views

EAPC - ipac

EAPC - ipac

EAPC - ipac

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

446 <strong>EAPC</strong> Abstracts<br />

Background: For decades there has been debate about the best way to ask<br />

patients to rate pain severity. A range of methods has been advocated,<br />

including numerical rating scales from 0 “no pain” to 10 “worst possible<br />

pain” (NRS-11), verbal rating scales with between 4 (VRS-4) to 7 (VRS-7)<br />

response options labelled with verbal descriptors, and visual analogue<br />

scales (VAS). There is extensive literature in the social sciences about rating<br />

scales, mainly dating from the 1950s to the late 1980s, as well as a number<br />

of publications about pain assessment. Two themes emerge. Firstly,<br />

determination of the optimal number of response options when using NRS<br />

or VRS scales. Secondly, comparison of VAS scales against NRS. The exact<br />

number of response options used in a scale is important. One or two extra<br />

options may increase reliability and better reflect the patient-to-patient variability.<br />

But, lengthier scales may increase the time to complete questionnaires,<br />

and place greater cognitive demands on frail patients. Aim: To<br />

review literature on rating scales, supplemented by empirical analyses of a<br />

pain database. Data and statistics: Patient data collected as part of the<br />

EPCRC project have been analysed by item response theory. Conclusions:<br />

Historical studies suggest that VRS with up to 7 options are increasing more<br />

powerful than VRS-4; VRS-5 to VRS-7 are generally preferred by patients<br />

as providing richer and more appropriate choice of response options. The<br />

two main contenders are NRS-11 and VRS-7. Results from analyses of<br />

EPCRC data are consistent with this hypothesis.<br />

Poster N°: 156<br />

Type of presentation: Poster<br />

Poster session: First Group 29 May Thursday, 10.30 to 30 May Friday<br />

13.00<br />

Category: Assessment & measurement tools<br />

Title: Outcomes in Patients Who Had Undergone Internal Hemipelvectomy<br />

(IH) versus External Hemipelvectomy (EH)<br />

Authors:<br />

Ying Guo Palliative Care and Rehabilitation Medicine M. D. Anderson<br />

Cancer Center U. STATES<br />

Karen Zhang M. D. Anderson Cancer Center Houston U. STATES<br />

Be-Lian Pei M. D. Anderson Cancer Center Houston U. STATES<br />

Jeanine Hanohano M. D. Anderson Cancer Center Houston U. STATES<br />

Christina Cote M. D. Anderson Cancer Center Houston U. STATES<br />

J. Lynn Palmer M. D. Anderson Cancer Center Houston U. STATES<br />

Gunjan Sharma M. D. Anderson Cancer Center Houston U. STATES<br />

Guddi Kaur M. D. Anderson Cancer Center Houston U. STATES<br />

Eduardo Bruera M. D. Anderson Cancer Center Houston U. STATES<br />

Background: Introduction: Hemipelvectomy is necessary in treatment of<br />

malignant pelvic tumors. This study compares the rehabilitation need and<br />

functional outcome of patients undergoing an IH versus EH. Methods:<br />

Charts from 30 patients who underwent IH and 30 patients who underwent<br />

EH during 1993–2005 were reviewed. Information collected<br />

include: demographic data; tumor diagnosis and treatment received; postoperative<br />

hospital length of stay (LOS); whether patient required physiatrist<br />

consult and/or acute inpatient rehabilitation stay; the length of rehabilitation<br />

stay; patients’ functional independence measure (FIM) score for<br />

gait upon discharge. We compared differences between the IH and EH<br />

groups using the Wilcoxon rank sum test, Chi-square test, and Fisher’s<br />

exact test. Results: The mean age (range) for IH was 47 (8–80) and 44<br />

(12–75) for EH groups. The male gender was 22/30 (73%) for IH and<br />

15/30 (50%) for EH groups. The preoperative chemotherapy and radiation<br />

treatment are similar between IH and EH groups (p=0.11 and 0.37)<br />

respectively. Rehabilitation consultation and acute in-patient rehabilitation<br />

stay was required for IH group 15/30 (50%) and 13/30 (43%); for EH<br />

16/30 (53%) and 16/30 (53%) respectively (p= 0.8, and 0.44) respectively.<br />

The mean (range) hospital LOS for patients who underwent EH was<br />

significantly longer than those who underwent IH (37 vs.19, p=0.0035).<br />

The mean rehabilitation LOS was similar (20 for EH vs. 22 days for IH<br />

patients, p=0.83). At the time of discharge, significantly higher percent of<br />

IH patients were able to ambulate without another person’s assistance<br />

14/30 (47%) vs. 5/30 (17%) in EH patient group, p=0.0125.<br />

Conclusions: Internal hemipelvectomy with limb salvage seems to be<br />

advantageous over external hemipelvectomy, in both hospital LOS and<br />

short-term functional recovery.<br />

Poster N°: 157<br />

Type of presentation: Poster<br />

Poster session: First Group 29 May Thursday, 10.30 to 30 May Friday<br />

13.00<br />

Category: Assessment & measurement tools<br />

Title: Karnofsky Index and survival<br />

Authors:<br />

Eva Gyllenhammar Löwet Närvård AB ASIH SWEDEN<br />

Jan Adolfsson Onkologiskt centrum Karolinska Universitetssjukhuset Solna<br />

SWEDEN<br />

Eva Thoren-Todoulos ASIH Löwenströmska sjukhuset SE-194 89 SWEDEN<br />

Background: Previous studies have shown that Karnofsky Performance<br />

Index (KPI) < 40 is associated with shorter survival time. In a palliative<br />

home care setting it would be of great value to have easily accessible<br />

tools to assess prognosis in terms of survival. Methods: All patients<br />

admitted to our advanced home care team during 30 months were<br />

assessed with KPI at the first home visit. The patients hade both nonmalignant<br />

and malignant diagnosis and were all in a palliative stage of<br />

their disease. KPI was noted in the electronic file of each patient and the<br />

file could not be completed without the assessment. Six senior doctors<br />

were involved. Results: 579 consecutive patients were included.<br />

One(1)KPI assessment was missing. 152 patients had non-malignant diseases<br />

and 426 had a disseminated cancer with rapidly progressing disease.<br />

The mean KPI at admission was 70. In the non-malignant group<br />

13 % (20/152) died during the study period, and in the cancer group 65%.<br />

(279/426) In the non-malignant group 52 % of the patients had a KPI<br />

equal 60 or lower at admission. The corresponding figure for the cancer<br />

patients was 31 %. For the group as a whole (579 patients) no correlation<br />

was found between KPI and time of survival. In the non-malignant group<br />

there was likewise no correlation to be found. In the malignant group<br />

there was a correlation between KPI and time of survival, which is significant<br />

at the 0,01 level. Conclusions: Our conclusion is that KPI on its<br />

own is not a useful tool to estimate prognosis in terms of time of survival<br />

in a mixed palliative patients’ population. The non-malignant patients<br />

hade a poorer KPI score at admission but a much better survival. In a palliative<br />

cancer patient group KPI might be useful but still approximately<br />

20 % of the patients were “long term survivors”.<br />

Poster N°: 158<br />

Type of presentation: Poster & poster discussion session<br />

Poster session: First Group 29 May Thursday, 10.30 to 30 May Friday<br />

13.00<br />

Category: Assessment & measurement tools<br />

Title: The Alberta Breakthrough Pain Assessment Tool for Research:<br />

A Validation Study<br />

Authors:<br />

Neil Hagen Oncology Tom Baker Cancer Centre and University of Calgary<br />

CANADA<br />

Cheryl Nekolaichuk University of Alberta Edmonton, Alberta CANADA<br />

Patricia Biondo Tom Baker Cancer Centre, Alberta Cancer Board Calgary,<br />

Alberta CANADA<br />

Linda Carlson Alberta Cancer Board and University of Calgary Calgary,<br />

Alberta CANADA<br />

Carla Stiles Tom Baker Cancer Centre, Alberta Cancer Board Calgary,<br />

Alberta CANADA<br />

Kim Fisher Alberta Cancer Board Calgary, Alberta CANADA<br />

Robin Fainsinger Alberta Cancer Board and University of Alberta<br />

Edmonton, Alberta CANADA

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!